Now Playing:

(CPIX, GCOM, EXEL) CRWENewswire Stocks to Watch

Category: News & Events

Views: (151)

Duration: (00:01:13)

Uploaded: 2012-02-08 20:49:01

BBC (Bulletin Board Code):
Embed code:
<embed src="http://agilevids.com/player.swf" width="480" height="336" bgcolor="FFFFFF" allowscriptaccess="always" allowfullscreen="false" flashvars="flvsource=http://agilevids.com/uploads/XcRPlvIFPMuGraIEJWPM.flv&preview_image=http://agilevids.com/uploads/player_thumbs/XcRPlvIFPMuGraIEJWPM.jpg&backgcolor=FFFFFF&autoplay=false&url_logo=http://agilevids.com/themes/polaris/images/logo-player.png&logo=top_right&floating_navbar=false&color_nav_bar_top=0x32556F&color_nav_bar_bottom=0xd7d7d7&ads_background_color=0x00CCFF&ads_border_color=0xCCCCCC&scrubber_position_color=0x32556F&scrubber_load_color=0x888888&scrubber_background_color=0xBBBBBB&volume_bar_color=0xBBBBBB&aspect_ratio=stretch"></embed>
or: Get Custom Embed Code

(0) (0 Votes)

Description: (More Info)
On its Second Quarter Fiscal 2012, Globecomm Systems Inc - GCOM - posted revenue of $95.2 million, a 35.5% increase year over year. Exelixis Inc - EXEL - reported results for the fourth quarter 2011, posting revenues of $9...

On its Second Quarter Fiscal 2012, Globecomm Systems Inc - GCOM -
posted revenue of $95.2 million, a 35.5% increase year over year.
Exelixis Inc - EXEL - reported results for the fourth quarter 2011,
posting revenues of $93.3 million, compared to $40.8 million for the
comparable period in 2010. Cumberland Pharmaceuticals Inc - CPIX -
reported that it has received a Notice of Allowance from the United
States Patent and Trademark Office relating to its new formulation
of Acetadote (acetylcysteine) Injection, which is used to treat
acetaminophen poisoning.

*********************

THIS IS NOT A
RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at
http//crwenewswire.com/disclaimer).
Tags: acetylcysteine acetaminophen Cumberland Globecomm Exelixis GCOM EXEL CPIX NasdaqCPIX NasdaqEXEL NasdaqGCOM